These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15007915

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rationale for monitoring cyclosporine concentration at 2 hours after administration in infants posttransplantation.
    Furlan V, Lykavieris P, Maubert MA, Habes D, Debray D.
    Transplant Proc; 2009 Oct; 41(8):3333-4. PubMed ID: 19857744
    [Abstract] [Full Text] [Related]

  • 24. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R.
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic drug monitoring of cyclosporine.
    Midtvedt K.
    Transplant Proc; 2004 Mar; 36(2 Suppl):430S-433S. PubMed ID: 15041380
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
    Wang CH, Chou NK, Wu FL, Ko WJ, Tsao CI, Chi NH, Hsu RB, Wang SS.
    Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
    [Abstract] [Full Text] [Related]

  • 27. [C0 vs C2 levels and their implications in kidney transplantation].
    Cuero C, Delgado E, de González M, Medina C, Vernaza A, Moscoso J.
    Rev Med Panama; 2002 Sep; 27():30-3. PubMed ID: 16737196
    [Abstract] [Full Text] [Related]

  • 28. Correlation Between C2 and AUC(0-4) in Renal Transplant Patients Treated With Diltiazem.
    Aros CA, Schneider HO, Flores CA, Ardiles LG, Alruiz PA, Jerez V, Mezzano SA.
    Transplant Proc; 2005 Apr; 37(3):1580-2. PubMed ID: 15866679
    [Abstract] [Full Text] [Related]

  • 29. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
    Higgins RM, Kanji H, Hernon M, Harrison P, Lam FT, Kashi SH.
    Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic drug monitoring of cyclosporine.
    Jorga A, Holt DW, Johnston A.
    Transplant Proc; 2004 Mar; 36(2 Suppl):396S-403S. PubMed ID: 15041374
    [Abstract] [Full Text] [Related]

  • 31. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C, Seto W, Taylor T, Saunders EF, Doyle J, Dupuis LL.
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [Abstract] [Full Text] [Related]

  • 32. Pharmacologic monitoring and outcomes of cyclosporine.
    Pollard SG.
    Transplant Proc; 2004 Mar; 36(2 Suppl):404S-407S. PubMed ID: 15041375
    [Abstract] [Full Text] [Related]

  • 33. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.
    Ragette R, Kamler M, Weinreich G, Teschler H, Jakob H.
    J Heart Lung Transplant; 2005 Sep; 24(9):1315-9. PubMed ID: 16143250
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion.
    Cantarovich M, Barkun J, Giannetti N, Cecere R, Besner JG, Tchervenkov J.
    Transplant Proc; 2004 Mar; 36(2 Suppl):442S-447S. PubMed ID: 15041383
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y, Zhang XD, Wang Y.
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [Abstract] [Full Text] [Related]

  • 37. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I, Boletis JN.
    Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [Abstract] [Full Text] [Related]

  • 38. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
    Hangler HB, Ruttmann E, Geltner C, Bucher B, Nagiller J, Laufer G, Mueller LC.
    Clin Transplant; 2008 Mar; 22(1):35-40. PubMed ID: 18217903
    [Abstract] [Full Text] [Related]

  • 39. [The clinical usefulness of cyclosporine therapeutic monitoring].
    Di Fede G, Iacò V, Pepe S, Salerno L.
    Clin Ter; 1999 Mar; 150(5):339-42. PubMed ID: 10687263
    [Abstract] [Full Text] [Related]

  • 40. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions.
    Knoop C, Vervier I, Thiry P, De Backer M, Kovarik JM, Rousseau A, Marquet P, Estenne M.
    Transplantation; 2003 Aug 27; 76(4):683-8. PubMed ID: 12973109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.